Ebos Group Limited · NZX:EBO
Ebos — UBS Australasia Conference 2019
22 slides from Ebos's conference presentation, Nov 18, 2019
Slide 1: UBS Conference Presentation
18 November 2019 For personal use only NZX/ASX Code: EBO UBS CONFERENCE PRESENTATION Please find attached a copy of a presentation to be made at the UBS Australasia Conference today. Janelle Cain General Counsel EBOS Group Limited For further information, please contact: Shaun Hughes Chief Financial
Slide 2: EBOS Group Limited - Business Overview
For personal use only EBOS Group Limited - Business Overview UBS Australasia Conference 18th November 2019
Slide 3: Disclaimer
DISCLAIMER The information in this presentation was prepared by EBOS Group Ltd with due care and attention. However, the information is supplied For personal use only in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliabil
Slide 4: Business Snapshot
BUSINESS SNAPSHOT EBOS Group is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading marketer and distributor of For personal use only recognised consumer products and animal care brands NZ$4.0 bil
Slide 5: EBOS Group Overview
EBOS GROUP OVERVIEW Diversification within Healthcare & Animal Care is key to our business model For personal use only HEALTHCARE ANIMAL CARE CONTRACT COMMUNITY INSTITUTIONAL CONSUMER PRODUCT & RETAIL VET WHOLESALE LOGISTICS PHARMACY HEALTHCARE PRODUCTS BRANDS Hospitals Wholesale Aged care / GP Reta
Slide 6: Leading Market Positions & Scale
LEADING MARKET POSITIONS & SCALE EBOS has leading market positions across the Group in particular in hospital pharmaceutical wholesale and community pharmaceutical wholesale, in both Australia and New Zealand For personal use only Combined pharmacy and Hospital pharmaceutical hospital pharmaceutical
Slide 7: EBOS Strategic Approach
EBOS STRATEGIC APPROACH For personal use only Our Healthcare and Animal Care strategic focus is centred on: Leading Market Disciplined Capital Investing for Growth Positions Management We aim to have positions of Two types of investments: Cash generation to drive scale in the markets we scope for
Slide 8: Strategic Investments Are Driving Shareholder Returns
STRATEGIC INVESTMENTS ARE DRIVING SHAREHOLDER RETURNS Over $600m invested over the last five years For personal use only EBOS has a long history of successful M&A activity, with more than 20 acquisitions completed since 2000. Core to our strategy is: 1. The ability to identify and complete opportuni
Slide 9: Primed for Next Wave of Growth
PRIMED FOR NEXT WAVE OF GROWTH For over 34 years the Group has delivered long term sustainable returns for all Shareholders through our strategy of investing for growth and productivity. This has delivered Total Shareholder annualised For personal use only Returns of 18.1% over 34 years and a share
Slide 10: Healthcare
For personal use only Healthcare 9
Slide 11: Healthcare Segment
HEALTHCARE SEGMENT Solid underlying trading performance For personal use only 1 A$m FY19 FY18 Var$ Var% We are primarily known for our activity through Revenue 6,548.3 6,608.6 (60.3) (0.9%) Symbion in distributing medicines to both Australian pharmacy and hospitals. Our Underlying EBITDA 226.6 216.6
Slide 12: Contract Logistics
CONTRACT LOGISTICS For personal use only EBOS’ contract logistics businesses offer a wide range of services to pharmaceutical manufacturers, medical A$m FY19 FY18 Var$ Var% device suppliers and consumer healthcare companies in Revenue 518.0 454.2 63.8 14.0% Australia and New Zealand. GOR 67.2 61.2 6
Slide 13: Institutional Healthcare
INSTITUTIONAL HEALTHCARE Our institutional healthcare businesses play a key role in For personal use only supplying a range of products and services to public and A$m FY19 FY18 Var$ Var% private hospitals, doctors’ surgeries and aged care facilities. Revenue 2,292.7 2,239.6 53.1 2.4% GOR 209.7 195.5
Slide 14: Community Pharmacy
COMMUNITY PHARMACY Delivering pharmaceutical and over the-counter medicines to thousands of pharmacies across Australia For personal use only A$m FY19 FY18 Var$ Var% and New Zealand, EBOS’ wholesale businesses play a Revenue 3,704.1 3,871.4 (167.3) (4.3%) critical role in the provision of healthcare
Slide 15: Consumer Products
CONSUMER PRODUCTS Our consumer products division, Endeavour Consumer For personal use only Health, is responsible for bringing high quality, cost- effective products to market across Australia, New Zealand A$m FY19 FY18 Var$ Var% and International markets. Revenue 113.9 108.6 5.3 4.9% GOR 44.0 42.4
Slide 16: Animal Care
For personal use only Animal Care
Slide 17: Animal Care Segment
ANIMAL CARE SEGMENT Strong EBITDA performance reflecting continued growth in our key brands For personal use only The Animal Care business markets and distributes a wide range of products to pet retailers, veterinarians and grocery stores across Australasia. We also hold a retail A$m FY19 FY18 Var$
Slide 18: Financial Overview
For personal use only Financial Overview
Slide 19: Sustained Financial Performance
SUSTAINED FINANCIAL PERFORMANCE Consistent and sustained financial performance through a balance of complementary businesses is a key signature of our approach. For personal use only Underlying Earnings Per Share (A$ cents) Dividends Per Share (NZ$ cents) 68.5 71.5 63.0 H1 H2 58.5 NZ$ cents per shar
Slide 20: Strategic Focus Areas for Growth
STRATEGIC FOCUS AREAS FOR GROWTH For personal use only With the right mix of businesses that deliver consistency in our performance and with a strong balance sheet, we aim to: Continue to execute on both organic growth and strategic value accretive acquisitions. Leverage our position as the lowe
Slide 21: Questions
For personal use only Questions
Slide 22: www.ebosgroup.com
For personal use only www.ebosgroup.com